Methode Electronics Inc 8-K, filed Mar 18, 2021
Methode Electronics Inc (MEI)
About this 8-K
Methode Electronics Inc filed this 8-K on March 18, 2021.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
|
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: (
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
|
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 18, 2021, upon the recommendation of the Nominating and Governance Committee, the Board of Directors (the "Board") of Methode Electronics, Inc. (the "Company") increased the size of the Board from eleven to twelve members. Upon the recommendation of the Nominating and Governance Committee, the Board elected Janie Goddard as a director of the Company to fill the vacancy. Ms. Goddard will serve as a director until her successor is elected and qualified or until her earlier resignation or removal. Upon the recommendation of the Nominating and Governance Committee, the Board appointed Ms. Goddard to the Medical Products Committee.
Ms. Goddard, 49, is currently a Divisional Chief Executive for the Medical and Environmental Sector at Halma plc. Before joining Halma, Ms. Goddard served as Divisional President of the Detection & Analysis Business Unit at Novanta, where she led a portfolio of solutions for medical device OEMs. Prior to Novanta, Ms. Goddard served in leadership roles at Welch Allyn (acquired by Hill-Rom), Covidien (acquired by Medtronic), and Johnson & Johnson. Ms. Goddard also serves on the Board of Directors of ACON S2 Acquisition Corp., a special purpose acquisition corporation. She received a B.S. in Business Administration from Washington University in St. Louis and an M.B.A. from Harvard Business School.
Ms. Goddard will be compensated in a manner consistent with the Company’s other non-employee directors, as most recently described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on July 28, 2020.
A copy of the news release announcing the appointment of Ms. Goddard is attached as Exhibit 99.1 to this Current Report on Form 8-K.
|
Item 9.01 |
Financial Statements and Exhibits. |
|
|
(d) |
Exhibits: |
|
Exhibit Number |
|
Description |
|
99.1 |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
Company Name |
|
|
|
|
|
|
|
Date: March 18, 2021 |
|
By: |
/s/ Ronald L.G. Tsoumas |
|
|
|
|
Ronald L.G. Tsoumas |
|
|
|
|
Chief Financial Officer |
Exhibit 99.1
Methode Electronics Adds Janie Goddard to its Board of Directors
Chicago, IL – March 18, 2021 – Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application specific products and solutions, announced today the election of Janie Goddard as a director of the company.
Chairman Walter J. Aspatore said, “We are pleased to welcome Janie to our board of directors and look forward to leveraging her extensive business career. Janie is an experienced executive who brings a record of driving innovation and a background in strategic marketing and product development. Her depth and breadth of experience in key global industries will add significant perspective in the support of Methode’s growth strategy.”
Ms. Goddard is currently a Divisional Chief Executive for the Medical and Environmental Sector at Halma plc. Before joining Halma, Ms. Goddard served as Divisional President of the Detection & Analysis Business Unit at Novanta, where she led a portfolio of solutions for medical device OEMs. Prior to Novanta, Ms. Goddard served in leadership roles at Welch Allyn (acquired by Hill-Rom), Covidien (acquired by Medtronic), and Johnson & Johnson. Ms. Goddard serves as a director of ACON S2 Acquisition Corporation. She received a B.S. in Business Administration from Washington University in St. Louis and an M.B.A. from Harvard Business School.
About Methode Electronics, Inc.
Methode Electronics, Inc. (NYSE: MEI) is a global developer of custom engineered and application specific products and solutions with manufacturing, design and testing facilities in Belgium, Canada, China, Egypt, Germany, India, Italy, Lebanon, Malta, Mexico, the Netherlands, Singapore, Switzerland, the United Kingdom and the United States. We design, manufacture and market devices employing electrical, electronic, LED lighting, sensor, and radio remote control technologies. Our business is managed on a segment basis, with those segments being Automotive, Industrial, Interface and Medical.
Our components are found in the primary end-markets of the aerospace, appliance, construction, consumer and industrial equipment, communications (including information processing and storage, networking equipment, wireless and terrestrial voice/data systems), medical, rail, consumer automotive, commercial vehicle, and other transportation industries.
For Methode Electronics, Inc.
Robert K. Cherry
Vice President Investor Relations
rcherry@methode.com
708-457-4030
1
2